Delivery Order SPE2DB22D2214-SPE2DB23FS6FG
Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $2.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $789 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561798575 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a single product to be delivered between August 14-15, 2023. As the DLA supports Department of Defense procurement and supply chain needs, this order is likely associated with the agency's pharmaceutical prime vendor program and...
- The Defense Logistics Agency awarded a $3,819.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561696498 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The place of performance is Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to provide the specified medication for use in supporting Department of Defense health programs. Amerisourcebergen will perform as the prime contractor, with work beginning on...
- The Defense Logistics Agency awarded a $789 delivery order to Amerisourcebergen Drug Corporation for 4562187604 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle and will provide pharmaceutical products to the DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance spans from September 15 to September 18, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $3,260.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561620934 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order is to be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order supports the DLA's mission to provide logistics support for all military services and...
- The Defense Logistics Agency awarded a $3,487.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561368856 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract will be performed by Amerisourcebergen Corporate Office Division in Conshohocken, Pennsylvania from June 28 through June 29, 2023. As the DLA supports Department of Defense procurement and supply chain management, this delivery order likely provides pharmaceutical products in support of DoD health services and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,262 to Amerisourcebergen Drug Corporation for the product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 20, 2023 through September 21, 2023. As the Defense Logistics Agency is the Department of Defense's combat logistics support agency, this delivery order was...
- The Defense Logistics Agency awarded a $3,810 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562003582 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a period of performance from August 30, 2023 through August 31, 2023 and will be performed in Conshohocken, Pennsylvania. As a major component of the Department of Defense that manages global logistics operations for the Army, Navy, Air Force, Marine Corps, and Coast Guard, this delivery order...
- The Defense Logistics Agency awarded a $2,742.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562324355 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The delivery order was issued under an unspecified agency-wide contract vehicle to provide pharmaceutical products in support of Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 27-28, 2023. No...
- The Defense Logistics Agency awarded a $5,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561693354 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a period of performance from August 3, 2023 through August 4, 2023 and will be performed in Conshohocken, Pennsylvania. As a major component of the Department of Defense that manages global logistics operations for the Army, Navy, Air Force, Marine Corps, and Coast Guard, this order supports the DLA's mission to...
- The Defense Logistics Agency awarded a $13,617 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561738036 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order was placed under an unspecified governmentwide acquisition contract vehicle and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by August 9, 2023 to support the Department of Defense. No set-aside designation or subcontractors were indicated. The Defense Logistics Agency manages...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB23FS6FGDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,630 to Amerisourcebergen Drug Corporation for 4562179229 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a period of performance from September 14, 2023 through September 15, 2023 for delivery to a location in Conshohocken, Pennsylvania. As the DLA supports procurement for the Department of Defense, this order is likely associated with the agency's medical supply chain and will deliver the specified pharmaceutical product to support treatment needs within the DoD healthcare system. No subcontractors or set aside designations were indicated.
Generated 12/23/23, 1:48 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/14/23 |